
Anglo-French Drugs & Industries Ltd Unlisted Shares
₹1,601.25▲ +0.00%Indicative price history
Indicative levels compiled by our team for information only — not a price feed, quote, or offer to deal.
About Anglo-French Drugs & Industries Ltd
Financial Performance
Consolidated figures in ₹ Crore, from annual reports and public filings.
| Indicators | 2026 | 2025 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 129.4 | 118.0 | 166.1 | 154.8 | 131.7 | 129.8 | 112.4 |
| Expense | 99.6 | 105.0 | 156.7 | 137.4 | 117.8 | 122.2 | 119.2 |
| EBITDA | 29.8 | 13.0 | 9.4 | 17.4 | 13.9 | 7.6 | -6.8 |
| Other Cost | 7.0 | 5.1 | 7.2 | 7.8 | 10.3 | 8.5 | 6.1 |
| PBT | 22.8 | 7.9 | 2.2 | 9.6 | 3.6 | -0.9 | -12.9 |
| Tax Expense | -0.1 | 0.7 | 0.4 | 2.1 | 0.6 | 0.0 | -1.7 |
| PAT | 22.8 | 7.2 | 1.9 | 7.5 | 3.1 | -0.9 | -11.2 |
| Other Inc./Exp. | 0.1 | -0.1 | 0.0 | -0.3 | -0.2 | 0.4 | 0.2 |
| Net Income | 22.9 | 7.1 | 1.9 | 7.5 | 3.1 | -0.8 | -11.2 |
| Shares O/S | 0.11 | 0.11 | 0.19 | 0.13 | 0.12 | 0.12 | 0.12 |
| EPS (₹) | 202.00 | 62.00 | 16.00 | 5.80 | 2.70 | -0.70 | -9.70 |
| Rev. Growth % | 9.7% | -29.0% | 7.3% | 17.5% | 1.5% | 15.5% | — |
| EBITDA Mgn % | 23.0% | 11.0% | 5.7% | 11.2% | 10.6% | 5.9% | -6.0% |
| Net Mgn % | 17.7% | 6.0% | 1.1% | 4.8% | 2.4% | -0.6% | -10.0% |
| EPS Growth | 225.8% | 287.5% | 175.9% | 114.8% | -485.7% | -92.8% | — |
Financials are as published on stockify.net.in and compiled from public filings. Refer to the audited annual report for exact figures.
Corporate Profile
Registered details, management and downloadable documents.